Skip to main content
. Author manuscript; available in PMC: 2014 Jun 19.
Published in final edited form as: Am J Cardiol. 2011 Sep 29;109(1):95–99. doi: 10.1016/j.amjcard.2011.08.010

Table 4. Risk classification by models including CHADS2 score and CHADS2 plus high-sensitivity C-reactive protein.

Individuals in the unshaded diagonal boxes did not change classification with the addition of high-sensitivity C-reactive protein. Dark grey shading indicates the number of individuals who were reclassified in a desirable direction when high-sensitivity C-reactive protein was added to the CHADS2 score; light grey shading indicates individuals who were reclassified in an undesirable direction. Data in parentheses are row percents.

Model with CHADS2 Model with CHADS2 plus high-sensitivity C-reactive protein
Predicted risk of death <30% 30–39% ≥40%
Participants who died during follow-up (n=134) <30% 80 (93) 5 (6) 1 (1)
30–39% 6 (27) 12 (55) 4 (18)
≥40% 0 (0) 2 (8) 24 (92)
Participants who did not die during follow-up (n=159) <30% 23 (100) 0 (0) 0 (0)
30–39% 13 (22) 41 (68) 6 (10)
≥40% 0 (0) 14 (18) 62 (82)